Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Materia receives metathesis funding

Swiss chemical maker will work with Germany's Max Planck Institute

by Alexander H. Tullo
October 30, 2006 | A version of this story appeared in Volume 84, Issue 44

Materia and University of Kansas chemistry professor Paul R. Hanson have received NIH funding for the further development of drug discovery reagents. Materia, formed in 1998 to commercialize olefin metathesis technology, says its ring-opening metathesis catalysts can streamline the development of druglike chemical libraries. The work will be conducted at the university's chemical methodologies and library development center, established in 2003 with funding from the National Institute of General Medical Sciences.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.